Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
72.1M
-
Number of holders
-
57
-
Total 13F shares, excl. options
-
17.7M
-
Shares change
-
+9.19M
-
Total reported value, excl. options
-
$73.6M
-
Value change
-
+$38.2M
-
Number of buys
-
46
-
Number of sells
-
-9
-
Price
-
$4.15
Significant Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q4 2019
62 filings reported holding OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share as of Q4 2019.
Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.7M shares
of 72.1M outstanding shares and own 24.62% of the company stock.
Largest 10 shareholders include Consonance Capital Management LP (2.89M shares), FMR LLC (2.08M shares), VANGUARD GROUP INC (1.49M shares), RENAISSANCE TECHNOLOGIES LLC (1.08M shares), AXA (868K shares), CHI Advisors LLC (844K shares), BVF INC/IL (734K shares), CITIGROUP INC (501K shares), WELLS FARGO & COMPANY/MN (474K shares), and BlackRock Inc. (451K shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.